Brunner Hr
Impact in
-
- Blood Pressure and Hypertension Studies
- Renin-Angiotensin System Studies
- Heart Failure Treatment and Management
- Heart Rate Variability and Autonomic Control
-
- Hormonal Regulation and Hypertension
Papers in
- Co-authors
- Michel BurnierBernard WaeberB. WaeberJ. NussbergerHaralambos GavrasLaragh JhJérôme BiollazD. B. Brunner
- Journals
- British Journal of Clinical Pharmacology (5 papers)Journal of Cardiovascular Pharmacology (1 paper)International Journal of Clinical Practice (1 paper)The Lancet (1 paper)PubMed (67 papers)
- Partner nations
- SwitzerlandFranceGermany
In The Last Decade
Brunner Hr
71 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Cardiology and Cardiovascular Medicine 761
- Endocrinology, Diabetes and Metabolism 363
- Family Practice 39
- Geriatrics and Gerontology 33
- Nephrology 56
Countries citing papers authored by Brunner Hr
This map shows the geographic impact of Brunner Hr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brunner Hr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brunner Hr more than expected).
Fields of papers citing papers by Brunner Hr
This network shows the impact of papers produced by Brunner Hr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brunner Hr. The network helps show where Brunner Hr may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Brunner Hr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Rationale for the use of very-low-dose combinations as first-line treatment of hypertension. | 2001 | 7 |
| 2 | 1999 | 41 | |
| 3 | Angiotensin II antagonists DuP 753 and TCV 116. | 1994 | 7 |
| 4 | Ambulatory blood pressure monitoring in children, adolescents and elderly people. | 1991 | 7 |
| 5 | Effects of intranasal administration of synthetic (4-28)human atrial natriuretic peptide to normal volunteers. | 1989 | 2 |
| 6 | Renin secretion responsiveness: understanding the efficacy of renin-angiotensin inhibition. | 1988 | 4 |
| 7 | What we would like to know about the antihypertensive mechanisms of angiotensin converting enzyme inhibition. | 1988 | 11 |
| 8 | Effect of eight-day converting enzyme inhibition on ambulatory blood pressure recordings in normotensive volunteers. | 1987 | 8 |
| 9 | [Therapeutic strategy in arterial hypertension]. | 1987 | 1 |
| 10 | Lack of a role of circulating bradykinin in the blood pressure response to acute angiotensin converting enzyme inhibition in rats. | 1987 | 14 |
| 11 | Preface: Swiss Hypertension Workshop on Vasopressin. | 1986 | 1 |
| 12 | Clinical pharmacology of atrial natriuretic (3-28) eicosahexapeptide. | 1986 | 18 |
| 13 | Responsiveness of renin secretion: a key mechanism in the maintenance of blood pressure. | 1986 | 3 |
| 14 | Blockade of the vascular effect of vasopressin in patients with mild essential hypertension. | 1986 | 4 |
| 15 | [Vasopressin in acute myocardial infarct: clinical implications]. | 1986 | 6 |
| 16 | 1985 | 18 | |
| 17 | Physiologic studies with saralasin in animals. | 1979 | 10 |
| 18 | Angiotensin II blockade in congestive heart failure. | 1978 | 1 |
| 19 | [Inhibition of plasmatic renin activity by potassium]. | 1967 | 10 |
| 20 | [Interrelations between potassium, renin and aldosterone]. | 1966 | 2 |
About Brunner Hr
Brunner Hr is a scholar working on Geriatrics and Gerontology, Family Practice, Cardiology and Cardiovascular Medicine, Nutrition and Dietetics and Genetics, having authored 75 papers that have together received 1.2k indexed citations. Recurring topics across this work include Vitamin K Research Studies (10 papers), Blood Pressure and Hypertension Studies (7 papers), Protein Hydrolysis and Bioactive Peptides (6 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers), Hormonal Regulation and Hypertension (6 papers), Heart Failure Treatment and Management (5 papers), Pharmaceutical studies and practices (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (761 citations), Endocrinology, Diabetes and Metabolism (363 citations), Family Practice (39 citations), Geriatrics and Gerontology (33 citations) and Nephrology (56 citations). Brunner Hr has collaborated with scholars based in Switzerland, France and Germany. Frequent co-authors include Michel Burnier, Bernard Waeber, B. Waeber, J. Nussberger, Haralambos Gavras, Laragh Jh, Jérôme Biollaz, D. B. Brunner, Ulrich Keller and W Vetter. Their work appears in journals such as British Journal of Clinical Pharmacology, Journal of Cardiovascular Pharmacology, International Journal of Clinical Practice, The Lancet and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.